What does an isolated Immunoglobulin G (IgG) p58 band on a Lyme disease Western blot indicate, and how should it be interpreted and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of an Isolated IgG p58 Band on Lyme Disease Western Blot

An isolated IgG p58 band does not meet CDC criteria for a positive Lyme disease Western blot and should be reported as negative. 1

CDC Diagnostic Criteria

The CDC requires ≥5 of 10 specific bands for IgG Western blot positivity, which include the 58 kDa band plus at least 4 additional bands (18,21,28,30,39,41,45,66, and 93 kDa). 1, 2 A single band of any type—including p58—does not constitute a positive result and represents a common diagnostic error when misinterpreted as evidence of infection. 1

Clinical Context and Testing Algorithm

Two-tiered testing is mandatory for proper interpretation:

  • Western blot should only be performed after a positive or equivocal first-tier EIA/ELISA. 1, 3 Performing Western blot without a preceding positive screening test violates CDC recommendations and increases false-positive rates. 3

  • For symptoms >30 days duration: Only IgG Western blot should be performed (not IgM), as IgM testing beyond 4-8 weeks is not clinically interpretable. 1

  • For symptoms <30 days duration: Both IgM and IgG Western blots should be performed if the first-tier test is positive/equivocal. 1 However, the IgM criteria require ≥2 of 3 specific bands (23,39,41 kDa) and do not include the 58 kDa band. 1

Specificity Concerns with Single Bands

The p58 band, while included in CDC IgG criteria, requires additional bands for specificity. 2, 4 European studies have identified p58 as one of several immunodominant proteins, but interpretation criteria consistently require multiple bands to distinguish true infection from cross-reactivity. 4, 5

Management Recommendations

Report the result as negative per CDC criteria. 1

  • If clinical suspicion for early Lyme disease remains high (symptom duration <30 days), repeat serologic testing in 2-4 weeks to allow antibody development rather than treating based on an insufficient Western blot. 1

  • If the patient has characteristic erythema migrans rash with appropriate epidemiologic exposure, diagnose and treat clinically without requiring serologic confirmation, as early Lyme serology has decreased sensitivity in the first weeks of infection. 1

  • Avoid using alternative laboratories that apply non-standard interpretation criteria, as these have demonstrated false-positive rates as high as 58% in healthy controls. 3

Critical Pitfall to Avoid

Interpreting fewer than 5 IgG bands as positive reduces test specificity and leads to misdiagnosis. 1 This is particularly problematic in low-incidence regions where the positive predictive value of Lyme serology can be as low as 10%. 3 If there is any question regarding interpretation, consult an infectious disease specialist. 3

References

Guideline

Lyme Disease Diagnosis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Western blotting in the serodiagnosis of Lyme disease.

The Journal of infectious diseases, 1993

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.